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Background: Self-monitoring of blood pressure is common but how telemonitoring (TM) 
with a mobile healthcare (mHealth) solution in the management of hypertension can be 
implemented by patients and health care professionals (HCPs) is currently unclear.   
Aim: Evaluation of the facilitators and barriers to self-monitoring and (TM) interventions for 
hypertension within the TASMINH4 trial. 
Design and Setting: Embedded process evaluation of Telemonitoring And Self-Monitoring in 
Hypertension (TASMINH4) randomised controlled trial (RCT), West Midlands, UK. Data 
analysed using Hamilton’s Rapid Analysis Approach. 
Methods: 40 participants comprising: 23 patients randomised to one of two arms, i) 
mHealth (self-monitoring by free text/SMS), ii) self-monitoring without mHealth (self-
monitoring using paper-diaries), 15 HCPs and two patient caregivers.  
Results: Four key priority areas relating to implementation of self-monitoring concerned i) 
acceptability of self-monitoring and telemonitoring to patients and HCPs ii) managing data 
iii) communication and iv) integrating self-monitoring in hypertension management 
(structured care). Structured home monitoring engaged and empowered patients to self-
monitor regardless of the use of mHealth. Telemonitoring potentially facilitated more rapid 
communication between HCP and patients.  Paper-based recording integrated into current 
work flows but required additional staff input.  
Conclusion:  
The convenience and ease of communication provided by telemonitoring was highly valued 
by all participants.  However, the realities of current UK General Practice meant that a 
paper-based approach to self-monitoring could be integrated into existing workflows with 
greater ease. Self-monitoring should be offered to all hypertensive patients, with 
telemonitoring likely to gain traction as clinical systems evolve to better allow integration 







How this fits in 
• Self-monitoring of blood pressure is common but how telemonitoring can be 
implemented routinely by healthcare professionals and patients is currently unclear. 
• This embedded process evaluation of the TASMINH4 trial highlights telemonitoring 
delivered by mobile phone was convenient and easy to implement in daily practice.   
• Healthcare professionals and patients valued the ease of communication from 
telemonitoring, and the automated calculation of average BP but found that paper-
based recording integrated better with current workflows in UK general practice. 
• Telemonitoring using an mHealth solution is a promising tool and should be offered for 
supporting hypertension self-management alongside traditional paper-based recording.  
 
BACKGROUND  
Mobile healthcare (mHealth), defined as the use of mobile and wireless technologies for 
health,[1] has the potential to improve access to and use of health services.  Digital health 
interventions that can be delivered by mobile phone offer scalable, potentially cost-effective 
ways to improve medication taking behaviours and include promising tools for supporting 
hypertension self-management.[2]  
Hypertension or high blood pressure (BP)[3] is the most significant risk factor globally for 
cardiovascular diseases (CVD) such as heart attack or stroke and lowering BP reduces these 
outcomes.[4-7] In England, approximately 30% of adult men and women have hypertension, 
with little recent change in prevalence, but many remain uncontrolled.[8]  Self-monitoring, 
with or without additional support such as provision of educational materials, tele-
counselling or telemonitoring (electronic transmission of BP data), has been shown to lower 
BP, with greater intensity of co-intervention associated with greater effect on BP.[9] 
Evidence for the use of BP self-monitoring values by GPs to titrate antihypertensive 
medication in primary care, has until recently been equivocal [10, 11] but this has changed 





TASMINH4, a national randomised controlled trial (RCT) in 138 General Practices was 
designed to evaluate clinician antihypertensive titration using self-monitored BP values 
either sent to clinicians by free short message service (telemonitoring) or manually posted 
to surgeries via paper diaries (self-monitoring alone).  After one year, those in both self-
monitoring groups had significantly lower systolic BP than those whose medication was 
adjusted using clinic readings.[12] The telemonitoring group had more rapid BP reductions 
and both groups were prescribed more antihypertensive medication.  No significant changes 
were detected in adherence to antihypertensive medication or to lifestyle factors. 
We carried out an evaluation of the trial processes to understand how the self-monitoring 
interventions used in TASMINH4 for BP management were implemented by patients and 
health care professionals (HCPs) to identify any facilitators and barriers promoting or 




The study population for this qualitative study included patients, their caregiver (defined as 
a spouse/friend/relative who identified themselves as helping patients with any aspect of 
hypertension management) and health care professionals (HCPs, employed in practices 
based in the West Midlands) taking part in the TASMINH4 RCT [ISRCTN 83571366, registered 
17 July 2014].[13] The TASMINH4 trial commenced in November 2014 and phased 
recruitment of patients to the present qualitative study commenced between March 2015 
and Sept 2016.  Patients aged over 35 with clinic BP not controlled below 140/90 mmHg 
were eligible for this process evaluation.[12] Patients not agreeing to participate were 
excluded. For practical reasons, all interviews were conducted in central England. 
Study Processes 
We consulted established criteria in the reporting of the present qualitative study.[14] Full 
details of the TASMINH4 interventions have been published previously.[12, 13]  In brief, 





Intervention Groups comprised: 
I. Self-monitoring alone (self-monitoring plus recording readings on paper diaries 
and posting these to the practice)  
II. Self-monitoring with telemonitoring (self-monitoring plus telemonitoring 
[sending readings via a SMS text based telemonitoring service with web-based 
data entry back up – mHealth solution] Figure 1)  
<Insert Figure 1> 
Following randomisation, all participants were asked to attend their own GP for a 
medication review. GPs used self-monitored BP to titrate antihypertensive medication in 
both self-monitoring groups. Participants randomised to usual care were managed with 
titration of antihypertensive treatment based on clinic BP measurements at the discretion of 
their attending HCP. (Box 1) Participants randomised to the self-monitoring interventions, 
self-monitored BP for twelve months. 
<Insert Box 1> 
 
Sampling Strategy 
Recruitment of participants were from a convenience sample of 2 areas, Birmingham and 
the Black Country (BBC) and West Midlands South (WMS), both regions within central 
England.  This area was chosen because together they cover a diverse range of patients in 
terms of levels of social deprivation and urban/rural diversity. Participants were 
purposefully sampled[15] to reflect a range of deprivation levels [16] and to ensure a range 
of views based on gender, participant (HCP or patient) and randomisation arm. Usual care 
participants were interviewed to add further context; however, because the present paper 
focuses on understanding the implementation of the self-monitoring interventions in 
management of hypertension their views are not reported here. Caregivers identified as 
assisting with self-monitoring were consented and interviewed separately in their homes. 
HCPs were interviewed at their respective practices. The flow of trial participants is outlined 






Design and data collection 
Interviews occurred between November 2015 and September 2016, parallel to trial data 
collection, recruiting participants after a minimum of six months of trial experience. They 
were conducted by multiple researchers (SGra, JH, PB, SM, LH, AT, CS) whose background 
and disciplines included health psychology, sociology and nursing.  Structured topic guides 
modified to suit each intervention arm were used, informed by a previous self-management 
study[17] (Suppl 2-4).  Each interview lasted approximately one hour, was audio-recorded 
and transcribed verbatim. Recruitment continued until data saturation for implementation 
themes was reached within patient and HCP groups separately.[18]  In line with our analysis 
approach below, we sought perspectives from three key informants involved directly in the 
trial (i.e. patients, their carers, and HCPs). 
Data Analysis 
Hamilton’s rapid analysis approach[19] was used to understand how patients and HCPs 
adopted the interventions.  This is a ‘tailored approach’ of an application of information and 
strategies for rapid cycle projects from the Rapid Assessment Process pioneered by John 
Beebe in 2001.  This approach has been used in many different fields by many different 
individuals.  Whilst the TASMINH4 trial was not in itself a rapid project, qualitative 
interviews were conducted alongside the trial and analysis of the incoming data was 
required to be assessed rapidly as part of the process evaluation.  Assessment of the data 
through team based qualitative enquiry involving multiple researchers in data collection and 
analysis enables intensive triangulated qualitative inquiry to iteratively provide 
understanding from the ‘insider’s’ perspective.[19, 20]  Distinct from other conventional 
approaches, this form of qualitative inquiry and methods is designed to give a preliminary 
understanding of key themes arising out of the data designed for situations where 
information is needed within a short timeframe (e.g. to inform a trial or where service 
change needs to be implemented quickly), rather than a more in-depth understanding.  
Importantly it uses methods which give a systematic approach to doing so. [19] Figure 2 
outlines the processes involved in the rapid analysis using templates (Suppl 5) developed by 
the researchers [SGra, JH, PB, SGre] based on the topic guides’ contents and derived for 





refined after a period of ‘road testing’[19]  and the domains were reclassified through a 
number of phases to yield the four key areas described below.  
<Insert Figure 2> 
RESULTS  
15 of the 18 practices selected, agreed to participate.  Of the 59 trial patients listed within 
these 15 practices, 39 were approached, six did not respond, and three declined to 
participate resulting in 47 interviewed participants (30 patients [including 7 usual care], 2 
caregivers, 15 HPs).  Characteristics of the study population and participating practices are 
detailed in Table 1.  
Four key priority areas emerged that relate to how the interventions were applied within 
participating practices.  The facilitators and barriers to self-monitoring and telemonitoring 
are summarised in Table 2 classified by priority area. 
 
Acceptability of self-monitoring/ telemonitoring to patients and professionals  
Regular home monitoring was preferred by patients to visiting the GP surgery for BP 
measurement.  Irrespective of the self-monitoring arm randomised into, patients felt 
“looked after” and found either method of communicating self-measured BP manageable. 
(Table 2) Patients who telemonitored described the process as a ‘slick operation’ whilst 
HCPs found the data provided electronically as “brilliant” for accessing quickly a monthly 
view of readings, and the graphing “awesome” in contrast to dealing with the paper-based 
records, which one GP described as “unwieldy”.(Table 2)  Amongst the telemonitoring 
group, patients liked being able to use their own mobile phone for sending BP readings 
electronically resulting in wider acceptance of the intervention amongst the more 
technophobe participants.  Similarly, HCPs favoured the rapid and direct mHealth solution 
for reviewing patients’ BP readings, over what they felt was the more time-consuming 
process of calculating means from the paper record.  Patients and HCPs recognised that 
telemonitoring may not be a suitable way of sending readings for all patients, such as the 
more elderly, and so felt a conventional paper record option was an important alternative. 






Each practice had autonomy regarding their management of patients and how self-
monitoring was implemented within their organisation. The trial specified that patients 
undertook self-monitoring following a standard schedule and posted or sent readings 
electronically. (Box 1) For manual recordings, GPs nominated a member of staff, usually the 
practice nurse or manager to handle the paperwork, calculate monthly BPs and enter this on 
to the practice clinical system for GP review. Whilst the paper based records integrated 
better within existing clinical systems via scanning documentation, HCPs favoured the rapid 
and direct mHealth solution over what they felt was the more time-consuming paper 
record.  Both self-monitoring interventions however ultimately required human effort to 
input the average monthly BP into the clinical system, which could have increased the 
likelihood of human error. 
HCPs set up personal reminder systems to review patients’ readings but, in some cases, 
where the designated nominated staff member was not present, GPs would have to deal 
with the paperwork personally.(Table 2) Although HCPs had to spend extra time logging into 
a separate web portal, the automatic calculation of average BP by the system meant GPs 
generally favoured telemonitoring over the manual written log.  Data confidentiality, 
security and the potential risk of important medical advice being received by the wrong 
person or easily missed were among concerns raised by some GPs over telemonitoring. 
(Table 3)  
Communication  
A key aspect of the interventions within TASMINH4 was for HCPs to manage and titrate 
medication using self-monitored BP.  Medication changes were recalled for patients in the 
telemonitoring arm only. For those requiring a change, and where BP values were seen out 
of normal range on the system prompted the GP to initiate contact. They felt this improved 
communication around BP resulting in more rapid control (Table 2 and 3).  For the few GPs 
using the text-back facility some felt complete advice was not always possible within one 
text and there was a need to safeguard confidentiality by keeping communication non-
committal so, in such cases, face to face follow up appointments were sometimes felt 





text) patients felt empowered from engaging in their own BP monitoring.  Those within the 
telemonitoring arm valued timely interaction with the system (and by extension their GP) 
and whilst text acknowledgement messages were automated when patients sent readings, 
they were nevertheless reassured from this instant feedback. 
Integrating self-monitoring in hypertension management (structured care)  
HCPs and patients adapted integration of self-monitoring into their BP management and this 
was illustrated within the telemonitoring arm. If patients could not use their existing mobile 
phone, though the study supplied patients with a phone, they borrowed a mobile phone or 
asked their partner or caregiver to send the SMS message.  Patients and HCPs found both 
self-monitoring systems and schedules easy to use.  Minor technical problems experienced 
with the mHealth system were alleviated after brief consultation with the study research 
team.  Conventionally GPs would undertake annual reviews of hypertensive patients, but 
both self-monitoring interventions enabled more intense monitoring and follow up with 
intervention where needed or reassurance where not.  Clinicians felt any decisions about 
medication changes for patients telemonitoring were based on a reliable database of BP 
readings. (Table 2 and 3) 
<Insert Table 2> 
<Insert Table 3> 
Discussion  
Summary  
The present qualitative process evaluation aimed to evaluate the facilitators and barriers to 
self-monitoring and telemonitoring within the TASMINH4 trial.  HCPs managed patients’ 
medications based on self-monitored readings as they would routinely, regardless of the 
mode of transfer.   
Telemonitoring of BP was convenient and therefore acceptable to most patients and HCPs 
with a notablyfew stating it was time consuming.  Telemonitored data facilitated regular 





decisions about intensifying medication for patients.  The paper-based option however 
integrated better with practice records offering a simple scan and storage process, directly 
matching the readings to the patient within the GP practice’s clinical system.  Integration 
has previously been documented as a requirement for accepting telehealth systems in the 
long term.[21, 22] Patients and HCPs agreed that telemonitoring may not suit all people 
across a wider population.  The benefits of structured care provided by both self-monitoring 
methods over standard clinical BP management were perhaps as important as the method 
of monitoring communication. 
Some concerns were raised over data confidentiality by clinicians as previously reported 
with mobile data usage;[23] these concerns could be reduced by limiting the advice given 
within the character allowance of one SMS and booking an additional face to face 
appointment in the event a medication change was needed, but clear advice to this effect 
would be necessary. This may reduce the potential savings in time associated with 
telemonitoring. 
Strengths and limitations 
This study was embedded within a large RCT[24] with flexibility regarding the 
implementation of mHealth within practices, avoiding the need for HCPs to adhere to strict 
protocols.  Qualitative approaches are ideal for exploring the mechanisms of adoption of 
such interventions and therefore important in maximising future dissemination.[25]  
Rapid analysis[19] is designed to enable a prompt preliminary understanding of key priority 
areas and key features of interventions when considering implementation in wider 
practice.[19, 26]  We therefore ensured a range of expertise within our team of researchers 
who were also responsible for the data analysis to facilitate this rapid process evaluation. 
The present analysis provides suggestions of the key areas relating to implementation to 
focus a deeper inductive analysis in the future by other researchers.[20, 26]  
Whilst purposive sampling was carried out in the present study with equal representation of 
men and women across the HCP and patient population, like the TASMINH4 national RCT 





findings and conclusions could be different if other medical practices had participated in the 
trial.  
Comparison with existing literature 
These findings are contrary to previous research investigating the use of self-management 
mHealth technology: a Swedish study [27]  of a mobile phone-base support system or 
platform and an Irish study by Morrison et al [28] of a smartphone application found 
participants expressed difficulty using the mobile platforms. Patients telemonitoring in the 
present study did not report such difficulties suggesting an advantage of using SMS (texts) 
enabling compatibility with patients’ existing environments and ease of delivering BP 
readings, key elements of telehealth interventions that ensure successful 
implementation.[29] Furthermore, our recommendation of the availability of an equally 
cost-effective[30] paper-based method of recording and sending readings is an additional 
way to facilitate wider appeal.  In a recent meta-ethnography of digital health interventions 
across wider health conditions, Morton et al [31] conclude engagement with such tools 
provides reassurance from the insight patients receive into their health.  This is both 
motivating and empowering for patients, supporting the findings of the present study and 
the conclusions of other studies relating specifically to hypertensive populations.[32, 33]   
Effective communication between hypertensive patients and GPs has been emphasised 
across several previous studies [34] and was identified as a key priority area for 
implementation.  The mobile texting system potentially enabled opportunity for discussion 
via consultation concordant with findings by Hallberg et al[27] and two recent systematic 
reviews that technology-based strategies that prompt and promote user engagement are 
more likely to be effective.[35, 36]  
Implications for clinical practice  
The present study suggests self-monitoring, whether it is using a mobile text-based system 
or a diary paper-based record, is relatively simple, cost effective[30] and potentially easy to 
adopt for managing hypertension in Primary Care.  A system whereby HCPs can be easily 
alerted to patients in whom intensification of anti-hypertensive BP medication is necessary 





recommended as a required alternative option to suit the broader population.  Overall, a 
system easily accessed by patients using their existing non-smartphone mobile phones 
makes this an acceptable form of telemonitoring.  
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